Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 6:e70064.
doi: 10.1002/btpr.70064. Online ahead of print.

Methylcellulose has synergistic growth benefits with poloxamer in suspension CHO culture

Affiliations

Methylcellulose has synergistic growth benefits with poloxamer in suspension CHO culture

Joshua S Katz et al. Biotechnol Prog. .

Abstract

Chemically defined cell culture media used in the growth of mammalian cells for biopharmaceutical applications is a complex mixture of various agents to promote cell growth and function. Poloxamer 188 (P188) is a well-known shear protectant added to media for use in CHO suspension culture but is not without drawbacks. This work explores the use of methylcellulose (MC), a well-known pharmaceutical polymer, in CHO media as an alternative and/or complementary additive to P188. IgG-producing DG44 CHO cell lines were cultured in a variety of suspension systems, up to 3 L reactors, to which MC and/or P188 were added. MC was an effective shear protectant in relatively lower shear systems but is less effective on its own in higher shear cultures. Across the range of conditions studied, MC and P188 were found to have a synergistic benefit with each other, where the combination of both additives produced cultures with higher viable cell densities than cultures containing either additive alone. These results indicate that MC is a viable option for use in media optimization studies as part of ongoing process intensification and optimization for CHO manufacturing.

Keywords: CHO; cell culture; cell media; methylcellulose; poloxamer.

PubMed Disclaimer

References

REFERENCES

    1. Szkodny AC, Lee KH. Biopharmaceutical manufacturing: historical perspectives and future directions. Annu Rev Chem Biomol Eng. 2022;13(1):141‐165. doi:10.1146/annurev‐chembioeng‐092220‐125832
    1. Kesik‐Brodacka M. Progress in biopharmaceutical development. Biotechnol Appl Biochem. 2018;65(3):306‐322. doi:10.1002/bab.1617
    1. Whitford WG, Lundgren M, Fairbank A. Cell culture media in bioprocessing. Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes. Elsevier; 2018;147‐162. doi:10.1016/B978‐0‐08‐100623‐8.00008‐6
    1. Jing Y, Borys M, Nayak S, et al. Identification of cell culture conditions to control protein aggregation of IgG fusion proteins expressed in Chinese hamster ovary cells. Process Biochem. 2012;47(1):69‐75. doi:10.1016/j.procbio.2011.10.009
    1. Das TK, Narhi LO, Sreedhara A, et al. Stress factors in mAb drug substance production processes: critical assessment of impact on product quality and control strategy. J Pharm Sci. 2020;109(1):116‐133. doi:10.1016/j.xphs.2019.09.023

Grants and funding

LinkOut - more resources